MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.24 (10.21%)	0.08 (3.19%)	0.13 (5.28%)	-0.16 (-5.82%)	0.24 (10.21%)	-0.01 (-0.75%)	0.9 (67.67%)	1.26 (94.74%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -28.7778
Diluted P/E:: -28.7778
RSI(14) 1m:: 73.68
VWAP:: 2.55
RVol:: 9.9607

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.12 +0.13 (+6.53%)	Oct 15 16:18
1m	Price increase 1m	2.12 +0.13 (+6.53%)	Oct 15 16:18